Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors

Feb 5, 1999Naunyn-Schmiedeberg's archives of pharmacology

Comparing how hallucinogenic drugs bind to three types of human serotonin receptors

AI simplified

Abstract

A notable positive correlation (r>0.9) exists between the affinities of 17 phenylisopropylamines at human 5-HT2A, 5-HT2B, and 5-HT2C receptors.

  • Structural modifications in phenylisopropylamines resulted in small differences in affinity for 5-HT2B receptors, with a range of only about 50-fold.
  • There is a significant correlation (r>0.9, n=8) between 5-HT2B receptor affinity and human hallucinogenic potency.
  • Despite the binding affinities to 5-HT2B receptors, 5-HT2A receptors are likely to play a more prominent role in the behavioral effects of hallucinogens.
  • Previous findings indicate that antagonists targeting 5-HT2A and 5-HT2C receptors block the stimulus effects of hallucinogenic phenylisopropylamines.

AI simplified

Full Text

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free